Although MS illness without MYCN amplification has a favorable prognosis in infants under the age of 12 months, the presence of stage MS NB in a newborn who is less than 2 months old is associated with a bad prognosis, regardless of the MYCN copy status, because of the complications [11]. Here, MYCN is linked to myeloid sarcoma.